CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenues
Obstructive sleep apnea (OSA)	$ 180,623	$ 126,120
Total revenues	180,623	126,120
Costs and expenses:
Cost of revenues	49,104	52,890
General and administrative	474,041	398,526
Depreciation	150
Total costs and expenses	523,295	451,416
Loss from operations	(342,672)	(325,296)
Other income (expense)
Interest expense	(432,126)	(363,521)
Settlement of prior accounting services	(240,000)
Other income	2,380
Total other income (expense)	(669,746)	(363,521)
Income taxes
Net loss	$ (1,012,418)	$ (688,817)
PER SHARE INFORMATION
Net Loss Per Common Share (in dollars per share)	$ (0.02)	$ (0.01)
Weighted Average Number of Common Shares Outstanding (in shares)	64,285,907	63,063,685